These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 3486026

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease.
    Sundström E, Fredriksson A, Archer T.
    Brain Res; 1990 Oct 01; 528(2):181-8. PubMed ID: 2271921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat.
    Sahgal A, Andrews JS, Biggins JA, Candy JM, Edwardson JA, Keith AB, Turner JD, Wright C.
    Neurosci Lett; 1984 Jul 27; 48(2):179-84. PubMed ID: 6333003
    [Abstract] [Full Text] [Related]

  • 9. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.
    Jarvis MF, Wagner GC.
    Life Sci; 1985 Jan 21; 36(3):249-54. PubMed ID: 3871245
    [Abstract] [Full Text] [Related]

  • 10. Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.
    Ricaurte GA, Langston JW, DeLanney LE, Irwin I, Brooks JD.
    Neurosci Lett; 1985 Sep 06; 59(3):259-64. PubMed ID: 3932903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Sep 06; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA, Jarvis MF, Wagner GC.
    Res Commun Chem Pathol Pharmacol; 1985 Jul 06; 49(1):145-8. PubMed ID: 3875884
    [Abstract] [Full Text] [Related]

  • 15. "In vivo" visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates.
    Hantraye P, Loc'h C, Tacke U, Riche D, Stulzaft O, Doudet D, Guibert B, Naquet R, Mazière B, Mazière M.
    Life Sci; 1986 Oct 13; 39(15):1375-82. PubMed ID: 3489875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increase of striatal dopamine turnover by stress in MPTP-treated mice.
    Urakami K, Masaki N, Shimoda K, Nishikawa S, Takahashi K.
    Clin Neuropharmacol; 1988 Aug 13; 11(4):360-8. PubMed ID: 3264755
    [Abstract] [Full Text] [Related]

  • 18. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP, Vassout A, Waldmeier P, Gentsch C.
    Eur J Pharmacol; 1998 Jul 17; 353(1):1-4. PubMed ID: 9721033
    [Abstract] [Full Text] [Related]

  • 19. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 17; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 20. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS.
    Brain Res; 1986 Jun 18; 376(1):117-24. PubMed ID: 3487376
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.